At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
High Velocity Therapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Wingate-type Exercise Test to Evaluate the Effect of High Velocity Therapy on Recovery Sensation and Blood Lactate Decline
In Brief
A clinical study evaluating High Velocity Therapy for Dyspnea and 5 related conditions. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The study will evaluate the impact of high velocity therapy (HVT) on reduction of work of breathing (as implied by breath frequency) and enhanced blood lactate decline during recovery from a Wingate-type Exercise test. The study will include four study segments, corresponding to four different therapy settings.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyspnea, Lactic Acidosis, Muscle, Breathlessness, Exercise, Recovery
CountriesUnited States
CollaboratorsAuburn University
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMar 2023
Primary CompletionJul 2023
First PostedAug 2023
Study CompletionDec 2023
TodayJul 2026
First PostedAug 9, 2023
Enrollment StartMar 6, 2023
Primary CompletionJul 31, 2023
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 2.9 years ago
Interventions
High Velocity Therapydevice
FiO2=100% with Flow=5LPM FiO2=21% with Flow=25-35LPM FiO2=100% with Flow=25-35LPM FiO2=21% with Flow=5LPM